HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC

MBL Life Sciences

Catalog No.: MBL-TS-M079-2

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: APC
• Immunogen: SSX-2
• Peptide Sequence: KASEKIFYV
• Class: Class I
• Sequence Location: 41-49
• MHC Allele: A*02:01